
Colin Kavanagh
+353 1 920 1196
[email protected]
Ten Earlsfort Terrace
Dublin 2
D02 T380
Ireland
Colin is a partner in the Corporate and M&A Group. He is head of the firm’s Life Sciences Group.
Colin provides corporate, commercial, regulatory and intellectual property advice across a range of industries but in particular the life sciences industry. Colin also advises clients in other intellectual property-based industries, including in the food, beverage, agri-business, media, telecoms, sports, entertainment and technology sectors. Colin advises on mergers, acquisitions and investments, cross-border tax and intellectual property re-organisations, post-acquisition integrations and corporate treasury activities. Colin advises on the drafting and negotiation of commercial contracts and arrangements across a range of sectors, with a particular focus on IP based industries. Colin also advises on the regulation of the life sciences and media industries in Ireland.
In The Legal 500: Europe, Middle East and Africa, 2024, Colin was ranked:
- Hall of Fame: Media & Entertainment
- Leading Individual: Healthcare & Life Sciences
Relevant Experience
- Advising a Danish co-operative on the acquisition of a controlling interest in a Danish health and nutrition ingredients business.
- Advising a US pharmaceutical company on the disposal of a manufacturing plant to a Korean CMO
- Advising Spanish multinational on the acquisition of a Communications infrastructure business in Ireland
- Advising a Canadian business process outsourcing provider on an investment in an Irish business
- Advising the shareholders of an Irish medical device business on a sale to a US multinational
- Advising a US biotech company on the acquisition of an Irish biotech business
- Advising a range of business on supply, sourcing, outsourcing and contract manufacturing arrangements
- Advising pharmaceutical, medtech and biotech businesses on product clinical trials, reimbursement, promotional and transactional regulatory issues
- Advising an Irish telecoms provider on the establishment of a broadcasting platform and the acquisition of a sports broadcaster
- Advising a global media company on the acquisition of an Irish television station
- Advising on the disposal of a number of radio broadcasters to a global media company
Insights Blog

EU lawmakers focus on the Agri-Food Supply Chain with new legislative proposals

Ireland’s Programme for Government 2025: the Life Sciences and Healthcare lens

Health Technology Assessment Regulation – Applies as of 12 January 2025

Medical Devices Regulations – obligation to notify supply issues commences on 10 January 2025
Related Content

The EU Rings in New Changes for Product Liability and Product Safety

Intellectual Property team recognised in IP STARS 2024

Regulatory Investigations – A Guide to Dawn Raids

HSE and IPHA announce model Clinical Trial Agreement for tripartite clinical trials

Arthur Cox advises Chanelle Pharma on sale to Exponent

Intellectual Property team recognised in IP STARS 2023

Arthur Cox contributes to IBA’s Comparative Legal Guide on Telemedicine

2023 Priority Legislation for Publication in the Life Sciences Sector

Cambrex Corporation acquisition of Q1 Scientific Limited

Biosynth Carbosynth acquisition of Aalto Bio Reagents

PRA Health Sciences proposed acquisition by ICON plc

Arthur Cox named European Corporate Team of the Year

Arthur Cox Leads Mergermarket League Table

Arthur Cox tops Mergermarket M&A Legal Adviser league tables

Arthur Cox Tops Mergermarket M&A Legal Adviser League Tables

Arthur Cox Named M&A Legal Adviser of the Year for Ireland

2023 Priority Legislation for Publication in the Healthcare Sector

Arthur Cox contributes to ICLG Pharmaceutical Advertising 2022

In Vitro Diagnostic Medical Devices Regulation enters into full effect

International Comparative Legal Guide: Digital Health 2022

The Clinical Trial Regulation: Get Ready for Go-Live – Part 3

IPHA publishes new Framework Agreement on the Supply and Pricing of Medicines

The Clinical Trial Regulation: Get Ready for Go-Live – Part 2

The Clinical Trial Regulation: Get Ready for Go-Live – Part 1

IPHA model Clinical Trial Agreement

Arthur Cox contributes to ICLG Pharmaceutical Advertising 2021

What you need to know about the new Regulation on transparency of risk assessment in the food chain

HPRA establish Compliance Programme on Advisory Boards

2021 priority legislation for publication in the Healthcare and Life Sciences sectors

Arthur Cox contributes to Practical Law’s Life Sciences Global Guide 2021

Updates to the Irish Pharmaceutical Healthcare Association (“IPHA”) Codes

Impact of EU/UK Trade and Cooperation Agreement on Life Sciences Sector

New Medical Device Regulations – Are You Ready?
